Thermo Fisher Experts will demonstrate its various capabilities at CPHI Frankfurt 2022.
Thermo Fisher Scientific will showcase its expertise, innovations, and capabilities to help pharmaceutical and emerging biotech companies via various modalities and platforms, including cell and gene therapies, oral solids, steriles, and biologics at CPHI Frankfurt 2022. Thermo Fisher experts will be available at CPHI Frankfurt 2022, Nov. 1-3, 2022, Booth #90J10, Hall 9.
"As pharma and biotechs look to transform molecules to medicines, they are looking for integrated solutions that connect the entire value chain from early development and clinical trials to scalable manufacturing and integrated sourcing," said Leon Wyszkowski, president of commercial operations, pharma services, Thermo Fisher Scientific, in a company press release. “This week, we will demonstrate our deep expertise across a range of topics — from clinical research and advanced therapies to digital technologies — to help our customers accelerate their innovation and speed the delivery of breakthrough medicines and therapies to patients.”
For more about Thermo Fisher sessions and activities at CPHl Frankfurt, visit this page.
Source: Thermo Fisher Scientific
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.